Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full-intake Dietary Monitoring
NCT ID: NCT06919471
Last Updated: 2025-11-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
90 participants
INTERVENTIONAL
2025-04-08
2030-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Secondary Objectives Assess the efficacy of the snack tracking app versus standard self-monitoring as measured by changes in the following measures between baseline and follow up; percentage weight change, weight loss self-efficacy scores, food logging self-efficacy scores, GODIN leisure time activity questionnaire scores, Vioscreen tool responses for stages of change for fats and fruit/vegetable intake, daily fruit consumption, daily vegetable consumption, servings of sweets per day, Healthy Eating Index (HEI) Score for calories from solid fats, alcohols, added sugars, HEI empty calories, total drinks of alcohol per day, calories from alcoholic beverages per day, added sugars by available carbohydrates, added sugars by total grams of sugar, calorie intake, carbohydrate intake, fat intake, saturated fatty acid intake, and total sugar intake.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1: MySnackTracker
Participants in Group 1 will use MySnackTracker to track their dietary intake. Participants will be asked to log only high-calorie, low-nutrient food and drinks, or snacks" (for example, cookies, chips and dip, and alcohol). A full list of these foods and drinks is provided in the app.
MySnackTracker App
App to track your dietary intake
Group 2: Fitbit
Participants in Group 2, will use the Fitbit food logging app to track their dietary intake. Participants will be asked to log all food and drink intake.
Fitbit
Wear it on wrist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fitbit
Wear it on wrist
MySnackTracker App
App to track your dietary intake
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Access to internet connection, email address, and smartphone able to download the intervention app
* Current or previous participation in one of the following DFI cohorts: PA17-0584 (MERIT Study), Project CHURCH, High Risk Breast Cohort, Mexican-American Cohort, and rural cancer survivors from the Mind Your BEAT study
* Demonstrated ability to read and understand English. The study app is currently only available in English.
Exclusion Criteria
* Prisoners
* Anyone currently under 18 years of age
* Cognitively impaired participants
* Pregnant women (assessed by self-report)
* BMI less than 28 or greater than 40
* Self-reported previous or planned bariatric surgery
* Self-reported current or planned use of a GLP-1 agonist medication
* Self-reported current or planned participation in another weight loss intervention
* Cancer participants receiving active treatment
* Anyone currently unable to participate in the research for the duration of the study
* No current motivation to lose weight
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karen M Basen-Engquist, MD
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MD Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Karen M Basen-Engquist, MD
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2025-02486
Identifier Type: OTHER
Identifier Source: secondary_id
2025-0163
Identifier Type: -
Identifier Source: org_study_id